Status:
SUSPENDED
Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to Titrate the Anesthetic-Hypnotic Component of Anesthesia
Lead Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Conditions:
Scheduled General Anesthesia
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
Index computed in real time from Auditory Evoked Potentials have been described parallel to depth of anesthesia. The goal of the study was to compare general anesthesia guided on Auditory Evoked Poten...
Eligibility Criteria
Inclusion
- ASA status I-II patients
- aged 18 - 65 years
- scheduled for general surgery (except laparoscopic interventions) lasting longer than 1 hour.
Exclusion
- Body weight \< 70% or \> 150% ideal body weight
- neurological disorder and hearing disorders (being not able to communicate with the patient in a normal tone)
- use of any medication interfering with pharmacological effect of the study including alcohol misuse or drugs.
Key Trial Info
Start Date :
February 1 2003
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT00181051
Start Date
February 1 2003
Last Update
September 16 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Gustave-Roussy
Villejuif, France, 94800